Skip to main content
KBS_Icon_questionmark link-ico

 

Wong Group

The Wong Group has focused on various aspects of transplant immunology, including lymphatics and lymphoid organs in transplantation as well as novel strategies to prevent graft rejection.

It's current research is funded by the BHF to investigate the use of an immunotoxin to prevent chronic rejection in cardiac allografts. If successful, transplant recipients can have regular treatment that can dampen down their immune response which may result in longer graft survival.

Our partners

BHF

British Heart Foundation

Group lead

Wilson Wong

Wilson Wong

Reader in Transplant Immunology